Multi-centre clinical outcomes from Western Australia for a pragmatic one-year pathway for intravesical bacillus Calmette-Guerin

被引:0
|
作者
Tan, Albert
McCombie, Steve
Moe, Andrew
Viswambaram, Pravin
Dyer, John
Goodwin, Robert
Ha, Tanya
Kuan, Melvyn
Lozinskiy, Mikhail
Hayne, Dickon
机构
关键词
CARCINOMA; BLADDER;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
abs24
引用
收藏
页码:43 / 44
页数:2
相关论文
共 30 条
  • [1] Fremantle protocol: Multicenter clinical outcomes for a pragmatic protocol for intravesical bacillus Calmette-Guerin
    Tan, Kuok Liang
    Viswambaram, Pravin
    McCombie, Stephen
    Moe, Andrew
    Goodwin, Robert
    Kuan, Melvyn
    Ha, Tanya
    Lozinskiy, Mikhail
    Dyer, John
    Hayne, Dickon
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (06) : 697 - 705
  • [2] Systemic Bacillus Calmette-Guerin Infection One Year After Intravesical Immunotherapy Mimicking Sarcoidosis
    Kc, Yashswee
    Gupta, Mohit
    Reid, Gail E.
    Arif, Ayesha
    Adams, Elaine
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (11)
  • [3] Outcomes of Intravesical Bacillus Calmette-Guerin (BCG) in patients with Non-Muscle Invasive Bladder Cancer: A retrospective study in Australia
    Pillippuhewa, Chamodi
    Della-Fiorentina, Stephen
    Haghighi, Kayvan
    Chau, Wei
    Kok, Peey-Sei
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 61 - 61
  • [4] Clinical outcomes in a cohort of patients with T1 high grade urothelial bladder cancer not receiving intravesical bacillus Calmette-Guerin: a 15 year experience
    Goonewardena, S. A. S.
    Jayarajah, U.
    Kuruppu, S. N.
    Herath, H. M. K. B.
    Fernando, D. M. H.
    Vickneswaran, K.
    CEYLON MEDICAL JOURNAL, 2018, 63 (01) : 37 - 39
  • [5] Clinical outcomes in a cohort of patients with T1 high grade urothelial bladder cancer not receiving intravesical bacillus calmette-guerin: a 15 year retrospective analysis
    Goonewardena, S.
    Jayarajah, U.
    Kuruppu, S.
    Herath, K.
    Fernando, H.
    Vickneswaran, K.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 5 - 6
  • [6] A MULTI-INSTITUTIONAL ANALYSIS OF PATIENT OUTCOMES FOLLOWING INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT FOR NON-MUSCLE INVASIVE BLADDER CANCER
    Sangster, Pippa
    Symes, Andrew
    Walker, Roger
    Morley, Roland
    Thompson, Alan
    Dick, John
    Le Roux, Peter
    Sandhu, Sarb
    JOURNAL OF UROLOGY, 2010, 183 (04): : E524 - E524
  • [7] ONE-YEAR FOLLOW-UP RESULTS AFTER SEQUENTIAL INTRAVESICAL BACILLUS CALMETTE-GUERIN AND DEVICE-ASSISTED CHEMO-HYPERTHERMIA (MITOMYCIN C DELIVERED BY THE COMBAT BRS SYSTEM) FOR HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS ... A BACILLUS CALMETTE-GUERIN-SPARING STRATEGY
    Griffiths, T. R. Leyshon
    Green, William J. F.
    Grice, Peter T.
    Goddard, Jonathan C.
    Kockelbergh, Roger C.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E367 - E367
  • [8] Real-world treatment patterns and clinical outcomes of Japanese patients with non-muscle invasive bladder cancer receiving intravesical bacillus Calmette-Guerin treatment
    Miyake, Makito
    Kikuchi, Eiji
    Shinozaki, Kenta
    Piao, Yi
    Hayashi, Nobuya
    Koto, Ryo
    Jinushi, Masahisa
    Kobayashi, Takashi
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (10) : 1120 - 1129
  • [9] Sequential bacillus Calmette-Guerin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes
    Gan, Christine
    Amery, Suzanne
    Chatterton, Kathryn
    Khan, Muhammad Shamim
    Thomas, Kay
    O'Brien, Tim
    JOURNAL OF UROLOGY, 2016, 195 (06): : 1697 - 1703
  • [10] Re: Sequential bacillus Calmette-Guerin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes
    Shenoy, Sunil P.
    Marla, Prashanth K.
    Sharma, Pritam
    Batchu, Chandu Krishna
    Reddy, Vijayanand R.
    Pai, Vivek Mangalore
    JOURNAL OF UROLOGY, 2017, 197 (04): : 1173 - 1174